InvestorsHub Logo
Followers 2
Posts 251
Boards Moderated 0
Alias Born 05/29/2019

Re: Evil Rabbit post# 180774

Thursday, 08/26/2021 12:25:25 PM

Thursday, August 26, 2021 12:25:25 PM

Post# of 232562
Evil: These assertions you make are not true for me, thus are false.

"Everyone here knows the 13D do NOT have shareholders’ best interests in mind. Even their pawns know they aim to screw everyone over."

A. I am here and I believe 13D has shareholders best interest in mind.

B. Who are the pawns? If I am considered "a pawn" then I do not know, much less think, `13D aim to screw anyone over. In fact I think NP & SK as fellow shareholders will benefit handsomely from success of 13D.

The mission is the exactly same as current BOD & management: get LL approved and get LL to market. Current management has failed to execute these goals so far so I am considering the options.

Plans clearly laid out at https://www.advancingll.com
1. Propose a new board of qualified individuals for shareholders to decide on.
2. If they win, replace management
3. Support & guide new management to obtain FDA approval for LL
- all the same technical, regulatory and marketing assets remain in place.
- the clinical trials, lab studies, collaborations and partnerships remain ongoing
- one would hope that an outgoing CEO and BOD, as substantial shareholders, would have both the grace, business sense and fiduciary responsibility to transition to new leadership with continuity and support.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News